1. Home
  2. FLUX vs GBIO Comparison

FLUX vs GBIO Comparison

Compare FLUX & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLUX
  • GBIO
  • Stock Information
  • Founded
  • FLUX N/A
  • GBIO 2016
  • Country
  • FLUX United States
  • GBIO United States
  • Employees
  • FLUX N/A
  • GBIO N/A
  • Industry
  • FLUX Industrial Machinery/Components
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLUX Miscellaneous
  • GBIO Health Care
  • Exchange
  • FLUX Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • FLUX 26.9M
  • GBIO 29.2M
  • IPO Year
  • FLUX N/A
  • GBIO 2020
  • Fundamental
  • Price
  • FLUX $1.97
  • GBIO $0.34
  • Analyst Decision
  • FLUX Strong Buy
  • GBIO Strong Buy
  • Analyst Count
  • FLUX 2
  • GBIO 4
  • Target Price
  • FLUX $6.00
  • GBIO $7.33
  • AVG Volume (30 Days)
  • FLUX 74.8K
  • GBIO 1.1M
  • Earning Date
  • FLUX 08-15-2025
  • GBIO 08-06-2025
  • Dividend Yield
  • FLUX N/A
  • GBIO N/A
  • EPS Growth
  • FLUX N/A
  • GBIO N/A
  • EPS
  • FLUX N/A
  • GBIO N/A
  • Revenue
  • FLUX $63,074,000.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • FLUX $11.10
  • GBIO N/A
  • Revenue Next Year
  • FLUX $12.66
  • GBIO N/A
  • P/E Ratio
  • FLUX N/A
  • GBIO N/A
  • Revenue Growth
  • FLUX N/A
  • GBIO 146.47
  • 52 Week Low
  • FLUX $1.15
  • GBIO $0.30
  • 52 Week High
  • FLUX $4.75
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • FLUX 64.88
  • GBIO 45.19
  • Support Level
  • FLUX $1.36
  • GBIO $0.31
  • Resistance Level
  • FLUX $1.60
  • GBIO $0.37
  • Average True Range (ATR)
  • FLUX 0.13
  • GBIO 0.03
  • MACD
  • FLUX 0.04
  • GBIO -0.00
  • Stochastic Oscillator
  • FLUX 91.10
  • GBIO 39.09

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: